文献速递炎症性肠病

IBD母亲所生子女日托暴露与感染并发症

Day Care Attendance and Infectious Complications in Children Born to Mothers With Inflammatory Bowel Disease.
PubMed 文献 · Clin Gastroenterol Hepatol · 2021-02-04

本研究探讨母亲患炎症性肠病(IBD)的子代在出生后第一年参加日托是否增加感染率,并分析宫内生物制剂暴露的影响。既往研究未考虑日托暴露这一公认感染危险因素,本研究旨在填补此空白。

要点

  • IBD孕妇活动期炎症是临床复发的危险因素。
  • 宫内生物制剂暴露与不良妊娠结局及婴儿感染无关。
  • 既往研究未考虑出生后第一年日托暴露对感染的影响。

核心结论

  • 旨在确定IBD母亲所生子女在宫内生物制剂暴露后,第一年参加日托是否感染率增加。

局限性

  • 既往研究未考虑出生后第一年日托暴露这一感染危险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Active inflammation during pregnancy in women with inflammatory bowel disease (IBD) is a risk factor for clinical relapse.1,2 In utero exposure to biologics is not associated with adverse pregnancy outcomes3 or infections in infants born to mothers with IBD.1,2,4 However, prior studies did not account for day care exposure in the first year of life, which is an established risk factor for infection in the general population. We aimed to determine whether children born to mothers with IBD have an increased rate of infection when attending day care in the first year after exposure to biologic therapy in utero.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Long MD, Siegel CA, Abraham BP, et al. Day Care Attendance and Infectious Complications in Children Born to Mothers With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2021. PMID: 33549864. doi:10.1016/j.cgh.2021.02.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。